- Min.Order :1 Gram
- Purity: 99%
- Payment Terms : T/T
Keywords
ENMD-2076 1291074-87-7 ENMD-2076 seller ENMD-2076 supplier
Quick Details
- Appearance:
- Application:API
- PackAge:according to the request of customer
- ProductionCapacity:1|Kilogram|Month
- Storage:Low temperature dry and shady
- Transportation:according to the request of customer
Superiority:
We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway
inhibitors, pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom
synthesis, transfer of new drug patent and technology, technical cooperation, and process optimization.
Jinan Trio PharmaTech was founded by a core group of top overseas pharmaceutical chemists, Medical scientists and
business management experts, and is an enterprise of science and technology supported by the "Attracting High-
Level Talent Scheme" of Jinan government.
Details:
Jinan Trio PharmaTech Co., Ltd.
Year Establishment: 2008
Location: We are located at one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City
Our company was founded by a core group of top overseas pharmaceutical chemists, medical scientists business
management experts
We have built up solid cooperation with over twenty oversea companies over one hundred domestic companies
since the foundation
Specifications:
Name ENMD-2076
CAS Registry Number 1291074-87-7
Applications:
ENMD-2076 (ENMD-981693, ENMD2076) is a antiangiogenic and Aurora kinase inhibitor with IC50 of 3, 13, 350, 23,
40, 93 and 120 nM for Flt-3, AurA, AurB, Src, KDR/VEGFR2 and FGFR1.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View